Search Results
Jan 27, 2026, 09:02 ET Orchestra Life Sciences Expands into Europe to Support Radiopharmaceutical Execution, Appoints Vinod Ramnandanlal as President and Managing Director
Life Sciences (OLS) is a technical consultancy providing strategic support and scientific expertise to advance pharmaceutical therapies for cancer and rare diseases. The company specializes in engineering solutions, operational excellence, and quality compliance services for advanced therapy manufacturing
More news about: Orchestra Life Sciences
Jan 27, 2026, 09:00 ET On The Go Appoints Matt King as Chief Executive Officer
businesses."Matt is the right leader for On The Go at this moment," said Ed Sirhal, Chair of People & Talent Committee of On The Go. "He brings a rare combination of industry insight, sound judgment, and a people-first leadership philosophy. The Board has great confidence in Matt's ability to steward
More news about: OTG Management
Jan 27, 2026, 08:52 ET Montway Auto Transport Names Alberto Anguiano as Chief Operating Officer
readiness for new market opportunities."Alberto has been a cornerstone of our executive team, demonstrating the kind of strategic foresight that is rare in this industry," said Tom Gartland, Chairman and CEO of Montway Auto Transport. "His disciplined approach has helped us pursue aggressive growth while
More news about: Montway Auto Transport
Jan 27, 2026, 08:47 ET nRichDX and Hamilton Advance Automated Liquid Biopsy Sample Prep Solution with Unprecedented Capability
Hamilton Microlab STAR® liquid handling platform, enabling scalable, walk-away automation for sensitive rare-analyte extraction.
More news about: nRichDX and Hamilton
Jan 27, 2026, 08:46 ET The European Commission extended the Marketing Authorisation for Vueway® (gadopiclenol) in the European Union for use in pediatric patients under 2 years of age
agents (GBCAs) are widely and routinely used to enhance the diagnostic performance of magnetic resonance imaging (MRI) examinations. Gadolinium is a rare earth metal that has unique magnetic properties that make it useful for the use in MRI imaging.About Bracco ImagingBracco Imaging
More news about: Bracco Group
Jan 27, 2026, 08:29 ET /C O R R E C T I O N -- Orasis Pharmaceuticals/
machinery if vision is not clear (e.g., blurred vision). Exercise caution in night driving and other hazardous occupations in poor illumination.Rare cases of retinal detachment have been reported with miotics. Examination of the retina is advised in all patients prior to initiation of therapy. Advise
More news about: Orasis Pharmaceuticals
Jan 27, 2026, 08:23 ET MARPAI, INC. HIRES PHARMACY EXECUTIVE MIMI DAVIS AS PRESIDENT OF MARPAIRX TO DRIVE STRATEGIC GROWTH
acquired by Knipper in 2020. With a career spanning leadership roles in Pharmacy Benefit Management (PBM) and retail pharmacy operations, Davis brings a rare blend of operational rigor and innovative vision to the Marpai leadership team."MarpaiRx is at a pivotal inflection point, and we needed a leader
More news about: Marpai
Jan 27, 2026, 08:15 ET AGCO Foundation Partners with the University of Sydney to Boost Resilience in Rural Communities
and early-stage funding. RARE also offers opportunities for AGCO Foundation stakeholders to engage through guest lectures, mentorship, panel discussions and community events, fostering knowledge exchange and industry-university collaboration.Learn more about the RARE program
More news about: AGCO Corporation
Jan 27, 2026, 08:00 ET Atmosphera Appoints Beauty and Wellness Veteran Steve Raack as Chief Operations Officer
growth is a healthy sales team, and they're paired with a founder who is an esthetician with more than twenty years of hands-on experience. This is a rare alignment of product credibility, community leadership, and operational scale—and it's incredibly powerful.""With his deep operational experience
More news about: Atmosphera
Jan 27, 2026, 08:00 ET Skyhawk Therapeutics Announces Nine Month Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington's Disease
platform to deliver first-in-class small molecules for devastating diseases with no approved disease-modifying therapies."Huntington's disease is a rare, hereditary, and ultimately fatal neurodegenerative disorder that affects over 40,000 symptomatic patients in the United States, with hundreds of thousands
More news about: Skyhawk Therapeutics
Jan 27, 2026, 08:00 ET Skyhawk Therapeutics Announces Nine Month Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington's Disease
platform to deliver first-in-class small molecules for devastating diseases with no approved disease-modifying therapies."Huntington's disease is a rare, hereditary, and ultimately fatal neurodegenerative disorder that affects over 40,000 symptomatic patients in the United States, with hundreds of thousands
More news about: Skyhawk Therapeutics
Jan 27, 2026, 08:00 ET Edible Brands Appoints Angela Johnson as Chief Marketing Officer
instrumental in shaping how we think about growth, innovation and relevance across our brands," said Somia Farid Silber, CEO of Edible Brands. "She brings a rare ability to connect strategy, product innovation and brand storytelling in a way that delivers real impact. This expanded role reflects both her proven
More news about: Edible Brands, LLC
Jan 27, 2026, 08:00 ET SimBioSys Appoints Senthil Periaswamy as Chief AI & Technology Officer
detection. Previously, he held senior AI leadership roles at AstraZeneca, where he built predictive and patient-journey analytics supporting oncology and rare disease programs, and at iCAD, where as Chief Research Scientist and Senior Vice President of Clinical Innovation he led the development and clinical
More news about: SimBioSys
Jan 27, 2026, 08:00 ET Kazia Therapeutics Reports Encouraging Preliminary Clinical Responses in Ongoing Phase 1b Study of Paxalisib in Late-Stage Metastatic Triple-Negative Breast Cancer
Friend, M.D., Chief Executive Officer of Kazia Therapeutics. "Confirmed complete responses in metastatic triple-negative breast cancer are exceedingly rare, particularly in patients who have already progressed on standard therapies. These early data reinforce our belief that paxalisib has the potential to
More news about: Kazia Therapeutics Limited
Jan 27, 2026, 08:00 ET Frontline Managed Services Appoints Tim Britt as Chief Executive Officer
leadership transition."Tim is exactly the right leader for Frontline's next chapter," said Adam Glucksman, Partner at Broad Sky Partners. "He brings a rare combination of deep technical expertise, operational leadership, and experience scaling services businesses through periods of significant change. As
More news about: Frontline Managed Services
Jan 27, 2026, 06:55 ET RTX Reports 2025 Results and Announces 2026 Outlook
exposures due to new tax legislation or other developments in the U.S. and other countries in which RTX and its businesses operate; (18) the identified rare condition in powder metal used to manufacture certain Pratt & Whitney engine parts requiring accelerated removals and inspections of a significant
More news about: RTX
Jan 27, 2026, 06:00 ET Joseph Saveri Law Firm Welcomes Veteran Trial Lawyer Diane S. Rice as Partner
significantly strengthens our ability to represent consumers and protect their rights," said Joseph Saveri, founder of the firm. "Her career reflects a rare combination of courtroom skill, strategic insight, and a deep understanding of complex litigation. She bolsters our complex litigation and antitrust
More news about: Joseph Saveri Law Firm LLP
Jan 27, 2026, 05:44 ET The Torchbearers: Leading with Purpose and Passion
cultural awareness among young readers. Beyond literature, his engagement with legal scholarship and work connected to the Supreme Court of India reveal a rare synthesis of intellectual rigor and ethical responsibility. As founder of Vama Academy and BPA Foundation, he remains deeply committed to education
More news about: Kiteskraft Productions LLP
Jan 27, 2026, 04:13 ET Cybage Software Appoints Badhrinath Krishnamoorthy as Global President
at a significant point in its evolution, with a clear mandate to scale while continuing to deliver measurable value to our clients. Badhri brings a rare combination of strategic clarity, operational precision, and deep expertise in building technology-led businesses at scale. His leadership will be instrumental
More news about: Cybage Software
Jan 27, 2026, 04:10 ET EQT Foundation opens applications for breakthrough science grants to reduce dependence on critical minerals for the green transition
inputs in batteries and electrochemical systems, while remaining manufacturable and competitiveRare-earth-free magnets and machine designs: innovations that significantly reduce or eliminate rare earth elements in magnets, motors, and generators without unacceptable efficiency or performance trade-offsEarth-abundant
More news about: EQT
Jan 27, 2026, 03:00 ET Servier delivers solid performance in 2024/25 and confirms its forecasts for 2030
for rare forms of cancer with unmet medical needs, and get them to patients.Following approvals in the United States, Australia, Japan, and Brazil, Voranigo® has now been approved in Europe, bringing the total number of countries to nearly 45. Used to treat patients with a rare form
More news about: Servier
Jan 27, 2026, 03:00 ET Servier delivers solid performance in 2024/25 and confirms its forecasts for 2030
for rare forms of cancer with unmet medical needs, and get them to patients.Following approvals in the United States, Australia, Japan, and Brazil, Voranigo® has now been approved in Europe, bringing the total number of countries to nearly 45. Used to treat patients with a rare form
More news about: Servier
Jan 27, 2026, 03:00 ET Servier affiche une performance solide en 2024/25 et confirme ses projections pour 2030
Japon ou encore le Brésil, Voranigo® a été approuvé en Europe, soit au total dans près de 45 pays, pour les patients atteints d'une forme rare du cancer du cerveau, et plus de 5 500 patients sont traités aux Etats-Unis et dans le monde grâce à des programmes d'accès précoces. En parallèle,
More news about: Servier
Jan 27, 2026, 02:00 ET The European Commission extended the Marketing Authorisation for Vueway® (gadopiclenol) in the European Union for use in pediatric patients under 2 years of age
agents (GBCAs) are widely and routinely used to enhance the diagnostic performance of magnetic resonance imaging (MRI) examinations. Gadolinium is a rare earth metal that has unique magnetic properties that make it useful for the use in MRI imaging.About Bracco ImagingBracco Imaging
More news about: Bracco Group
Jan 26, 2026, 23:54 ET First in Asia: Concordia International School Shanghai Earns Prestigious NIAAA Award
in Asia to receive the National Interscholastic Athletic Administrators Association (NIAAA) Quality Program Award at the Exemplary Level. This is a rare distinction recognizing excellence in school athletics programs.
More news about: Concordia International School Shanghai